Projects per year
Anton Peleg is Professor of Infectious Diseases and Microbiology and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University. He is also a research group leader in the Department of Microbiology, Monash University. His research spans clinical to basic research, with a focus on hospital-acquired infections, antimicrobial resistance, infections in immunocompromised hosts and understanding mechanisms of disease caused by hospital pathogens. He has a particular clinical interest in complex infections in highly vulnerable patient groups, including patients with cystic fibrosis, lung and stem cell transplant recipients, and infections in patients with burns or in intensive care.
Anton is a founding member of the Monash Centre to Impact AMR, launched early 2020.
Infectious Diseases Physician, Alfred Hospital, Melbourne VIC
Bachelor of Medicine, Bachelor of Surgery, MONASH UNIVERSITY
Award Date: 19 Feb 2027
Microbiology and Infectious Diseases, Doctor of Philosophy, University of Queensland
2010 → …
Master of Public Health, Harvard University
2009 → …
Director Infectious Diseases Clinic, Alfred Health
Head of Travel Medicine Clinic, Alfred Health
Head, Victorian NPEP Service, Alfred Health
Executive, Monash Partners Academic Health Science Centre
Research area keywords
- antibiotic prescribing
- antibiotic resistance
- antimicrobial stewardship
- qualitative research
- hematopoietic stem cell transplantation
- microbial drug
- glycaemic control
- hospital-acquired infections
- antimicrobial resistance
- infections in immunocompromised hosts
1/01/21 → 31/12/24
27/08/20 → 27/08/21
31/03/20 → 30/03/23
1/07/19 → 30/06/21
Subedi, D., Archer, S. K., Morris, F. C., Oliveira, C., Kielty, L., Korneev, D., O’Bryan, M. K., Lithgow, T. J., Peleg, A. Y. & Barr, J. J., Feb 2021, In : Nature Microbiology. 6, 2, p. 157-161 5 p.
Research output: Contribution to journal › Article › Research › peer-reviewOpen Access
Larcombe, S., Jiang, J-H., Hutton, M. L., Abud, H. E., Peleg, A. Y. & Lyras, D., 31 Jan 2020, In : Journal of Medical Microbiology. 69, 2, p. 290-297 8 p.
Research output: Contribution to journal › Article › Research › peer-reviewOpen AccessFile
An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trialMcMahon, J. H., Lau, J. S. Y., Roney, J., Rogers, B. A., Trubiano, J., Sasadeusz, J., Molton, J. S., Gardiner, B., Lee, S. J., Hoy, J. F., Cheng, A. & Peleg, A. Y., 13 Oct 2020, In : Trials. 21, 1, 3 p., 847.
Research output: Contribution to journal › Letter › Other › peer-reviewOpen AccessFile
Peleg, A. Y. & Stewardson, A. J., Mar 2020, In : Infection, Disease and Health. 25, 2, p. 124-129 6 p.
Research output: Contribution to journal › Article › Research › peer-review
Stewardson, A., Naidu, R., Coghlan, B., Jenney, A., Kepas, J., Lavu, E., Munamua, A., Peel, T., Sahai, V., Tekoaua, R., Tudravu, L., Zinihite, J., Cheng, A., Rafai, E. & Peleg, A., 28 Apr 2020, In : BMJ Global Health. 5, 4, 8 p., e002418.
Research output: Contribution to journal › Review Article › Research › peer-reviewOpen AccessFile
Trevor Lithgow (Chair/Co-Chair), Max Cryle (Member), Kellie Tuck (Member), Ana Traven (Member), Thomas Naderer (Member), Julian Rood (Member), Dena Lyras (Member), Anton Peleg (Member), Mibel Aguilar (Member), Fasseli Coulibaly (Member), Sheena McGowan (Member), Meredith Anne Okeeffe (Member), Matthew Belousoff (Member) & Philip Heraud (Member)1 Mar 2017 → 1 Jan 2019
Activity: Industry, Government and Philanthropy Engagement and Partnerships › Membership of industry collaboration/ network